Show simple item record

dc.contributor.authorRugera, Simon Peter
dc.contributor.authorMcNerney, Ruth
dc.contributor.authorPoon, Albert K
dc.contributor.authorAkimana, Gladys
dc.contributor.authorMariki, Rehema Forgen
dc.contributor.authorKajumbula, Henry
dc.contributor.authorKamau, Elizabeth
dc.contributor.authorMpawenimana, Servilien
dc.contributor.authorSaid, Said Yusuf
dc.contributor.authorToroitich, Anthony
dc.contributor.authorRonoh, Wesley
dc.contributor.authorSollis, Kimberly A
dc.contributor.authorSonoiya, Stanley
dc.contributor.authorPeeling, Rosanna W
dc.date.accessioned2022-02-08T12:36:25Z
dc.date.available2022-02-08T12:36:25Z
dc.date.issued2014
dc.identifier.citationRugera, S. P., McNerney, R., Poon, A. K., Akimana, G., Mariki, R. F., Kajumbula, H., ... & Peeling, R. W. (2014). Regulation of medical diagnostics and medical devices in the East African community partner states. BMC health services research, 14(1), 1-7.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/1434
dc.description.abstractBackground: Medical devices and in vitro diagnostic tests (IVD) are vital components of health delivery systems but access to these important tools is often limited in Africa. The regulation of health commodities by National Regulatory Authorities is intended to ensure their safety and quality whilst ensuring timely access to beneficial new products. Streamlining and harmonizing regulatory processes may reduce delays and unnecessary expense and improve access to new products. Whereas pharmaceutical products are widely regulated less attention has been placed on the regulation of other health products. A study was undertaken to assess regulation of medical diagnostics and medical devices across Partner States of the East African Community (EAC). Methods: Data was collected during October 2012 through desk based review of documents and field research, including face to face interviews with the assistance of a structured questionnaire with closed and open ended questions. Key areas addressed were (i) existence and role of National Regulatory Authorities; (ii) policy and legal framework for regulation; (iii) premarket control; (iv) marketing controls; (v) post-marketing control and vigilance; (vi) country capacity for regulation; (vii) country capacity for evaluation studies for IVD and (viii) priorities and capacity building for harmonization in EAC Partner States. Results: Control of medical devices and IVDs in EAC Partner States is largely confined to national disease programmes such as tuberculosis, HIV and malaria. National Regulatory Authorities for pharmaceutical products do not have the capacity to regulate medical devices and in some countries laboratory based organisations are mandated to ensure quality of products used. Some activities to evaluate IVDs are performed in research laboratories but post market surveillance is rare. Training in key areas is considered essential to strengthening regulatory capacity for IVDs and other medical devices. Conclusions: Regulation of medical devices and in vitro diagnostics has been neglected in EAC Partner States. Regulation is weak across the region, and although the majority of States have a legal mandate to regulate medical devices there is limited capacity to do so. Streamlining regulation in the EAC is seen as a positive aspiration with diagnostic tests considered a priority area for harmonisation.en_US
dc.language.isoen_USen_US
dc.publisherBMC health services researchen_US
dc.subjectRegulationen_US
dc.subjectIVDen_US
dc.subjectDiagnostic testen_US
dc.subjectMedical deviceen_US
dc.subjectEast African communityen_US
dc.titleRegulation of medical diagnostics and medical devices in the East African community partner statesen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record